Walvax Biotechnology
在场
高管
查看带有其 23 名主要高管的组织结构图
Walvax Biotechnology 搜索最多的简介
- Runsheng Jiang, Director, President and Director
- Lingbing Zeng, Independent Director
- Ganghong Sun, Independent Director
高管在Walvax Biotechnology变化
- Shaozhong Dong 曾任 Vice President, 现任 Vice Chairman of the Board (新闻发布的2024八月9号).
创建提醒
跟踪 Walvax Biotechnology 的高管变动
生物技术
Walvax Biotechnology 拥有 2,336 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AusperBio 刚刚宣布为 73 筹款数百万美元。 (公布2025一月3号).
- Visus Therapeutics and Tenpoint Therapeutics have merged (公布2024十二月27号)..
- Deerfield has announced the acquisition of Singular Genomics (公布2024十二月24号).
生物技术 行业的其他推荐联系人
消息
Walvax Biotechnology 的最新新闻稿
- Walvax Strengthens Commitment to African Vaccine Manufacturing at EVMA Inaugural Event
- Walvax’s PCV13 Officially Exported to India
- Walvax Shares Vaccine Development Expertise at 11th National Vaccine Conference of Thailand
- Walvax Biotechnology Achieves ESG Rating Upgrade to BBB from MSCI
- New HPV vaccine from Zerun Bio receives WHO prequalification
- Walrinvax Pre-Qualified by WHO
- Walvax Participated in the Annual Investment Meeting (AIM) Congress 2024 in Abu Dhabi, UAE
- Media
- Walvax presents safety and non-inferior immunogenicity results of its MPV ACYW135 compared with Menactra® at Leading Scientific Conferences
- Walvax publishes data from the Phase 3b trial of Walrinvax in Vaccine
- View more press releases Close
